BioSpace News Archive

High blood pressure and high cholesterol are more common among workers exposed to loud noise at work according to a CDC study published this month in the American Journal of Industrial Medicine.

Titan Pharmaceuticals, Inc. announced that it has entered into a definitive asset purchase, supply and support agreement with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A.

Clinicians looking for effective alternatives to decolonizing the nose before surgery will be among the first to check out the Medline’s Ready.Set.Care. kit at the 2018 AORN Surgical Conference & Expo in New Orleans, March 24-28, at booth 829.

An innovative program launched in 2010 in Uganda has dramatically sped the detection of outbreaks of some of the world’s most dangerous viruses, according to a Centers for Disease Control and Prevention report published today in The Lancet Infectious Diseases.

New study of 91 patients with cutaneous melanoma is the third recent publication demonstrating that the DecisionDx-Melanoma test impacts one in two clinical management decisions.

Proceeds will support clinical development of lead program TC-210 and expansion of the multi-format TRuC™-T cell pipeline in solid tumors and blood cancers

Ronald Renaud to serve as chairman of Kyn’s board of directors

One of the largest gene therapy facilities received Facility of the Year Award for Project Execution from the International Society for Pharmaceutical Engineering

Mr. Harmel S. Rayat, longtime majority stockholder, appointed as Chairman of the Board of Directors.

Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices, announced today the appointment of Gregory Pomrink as Vice President, Research and Development to further leverage its six proprietary technologies across the company’s five key business units in Dental, Spine, Orthopaedic, Dural Repair and Nerve Repair Surgery.